A study to evaluate the physico-chemical and bacteriological quality of groundwater was carried out in the commune of mbankomo(Centre-Cameroon)at 4 wells and 4 springs during the period frommarch to *** physico-chemi...
详细信息
A study to evaluate the physico-chemical and bacteriological quality of groundwater was carried out in the commune of mbankomo(Centre-Cameroon)at 4 wells and 4 springs during the period from march to *** physico-chemical parameters were measured by the standard *** bacteria of fecal contamination,namely HAB(Heterotrophic Aerobic Bacteria),total and faecal coliforms(Escherichia coli),and faecal streptococci were isolated by the surface spreading technique on PCA(Plate Count Agar),Endo and BEA(Bile Esculin Azide)agar respectively,and sulphite-reducing clostridia by the incorporation method on Tryptone Sulfite Cycloserine(TSC)*** a physico-chemical point of view,the groundwater in mbamkomo is characterized by an average temperature(24.24±0.24°C);it is polluted with organic matter,acid and poorly *** was noted from a bacteriological point of view that these waters have a high and varied bacterial load with an average value of 100.8 × 10^(5) CFU/100 mL for coliforms,16.3 × 10^(5) CFU/100 mL for fecal streptococci,5.6 × 10^(5) CFU/100 mL for Escherichia coli and 4.8 ×10^(²)CFU/100 mL for Clostridium *** concentrations are all higher than the WHO(World Health Organization)standards which are set at 0 CFU/100 mL for coliforms,fecal streptococci and Clostridium perfringens and indicate fecal pollution of these *** coli cell densities were significantly correlated with dissolved oxygen in the water(r=0.510;pmity to pollution sources,poor maintenance and poor protection of the *** waters,without any treatment,are not recommended for human consumption according to the standards of the WHO.
Purpose: Although controversial, assessment of epidermal growth factor receptor (EGFR) expression is required for the approved indications of Cetuximab in metastatic colorectal cancer (mCRC). With the objective of imp...
详细信息
Purpose: Although controversial, assessment of epidermal growth factor receptor (EGFR) expression is required for the approved indications of Cetuximab in metastatic colorectal cancer (mCRC). With the objective of improving patient selection, “ERBITUX-OUEST” study aimed at analyzing EGFR status in a large cohort of mCRC patients who received cetuximab without preliminary EGFR screening, and assessing the correlation between EGFR status and response to treatment retrospectively. Patients and methods: 332 patients treated with Irinotecan Cetuximab based regimen after progression on irinotecan or oxaliplatin therapy were included. EGFR status was assessed using three available immunohistochemistry (IHC) tests and in situ hybridization in case of negativity. Clinical outcomes of EGFR-positive and EGFR-non-detected (or considered as negative with at least one test) patients were compared. Results: Of the 332 samples centrally screened, 194 were classified as full-positive (i.e., EGFR-positive for all three tests), 86 as full-negative, and 52 as discordant. One third of the 131 negative samples with FDA approved test should be reclassified as positive with at least one of the two others tests. Regarding results from FDA approved test only, neither objective response rate (ORR), progression-free survival (PFS) nor overall survival (OS) differed significantly between EGFR-negative and EGFR-positive patients (P = 0.788, 0.326 and 0.888, respectively). Similarly, comparison of full-negative to other groups did not show any significant difference in terms of ORR (P = 0.507), PFS (P = 0.222) or OS (P = 0.686). Conclusion: These data strongly argue against mCRC patients selection for Cetuximab treatment based on EGFR expression as measured by currently available IHC technics.
暂无评论